MRI Enhancement Predicts Breast Cancer in BRCA Mutation Carriers Edited By Amy Norton July 09, 2026 Cancer Epidemiol Biomarkers Prev. 2026; doi:10.1158/1055-9965.EPI-25-1952

https://www.medscape.com/viewarticle/mri-enhancement-predicts-breast-cancer-brca-mutation-2026a1000na7?src= In a retrospective study, higher quantitative background parenchymal enhancement (BPE) on breast MRI was associated with increased cancer risk among women with BRCA1/2 mutations — suggesting BPE could help refine risk assessment.